학술논문
Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland
Document Type
Article
Author
Wildman, Eden; Rampling, Tommy; Morris, Sheila; Shoemaker, Kathryn; Aksyuk, Anastasia; Padilla, Marcelino Giune; Roe, Tiffany; Petropoulos, Christos J; Wrin, Terri; Colton, Hayley; Bisnauthsing, Karen; Smith, Catherine; Leeman, Lucy; Galloway, James; Nagra, Deepak; Lazarus, Rajeka; Penciu, Florentina; Hunter, Ewan; Sahdev, Anju; Turner, David; Royal, Simon; Uriel, Alison; Ustianowski, Andrew; Moran, Ed; Green, Christopher; Desai, Amisha; Lakeman, Nicki; Moore, Patrick; Whittington, Ashley; Kobielusz Gembala, Iwona; Konieczny, Marek; Ramasamy, Maheshi N ; Kelly, Elizabeth J ; Seegobin, Seth ; Dargan, Paul I; Payne, Ruth; Libri, Vincenzo; Adam, Matthew; Aley, Parvinder K; Martinez-Alier, Nuria; Church, Alison; Jepson, Brett; Khan, Mark; Matthews, Sam; Townsend, G Todd; Vekemans, Johan; Bibi, Sagida; Swanson, Phillip A, II; Lambe, Teresa; Pangalos, Menelas N; Villafana, Tonya; Pollard, Andrew J; Green, Justin A
Source
In The Lancet Microbe November 2023 4(11):e863-e874
Subject
Language
ISSN
2666-5247